1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Poland Pharmaceuticals and Healthcare Report Q4 2016

Poland Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates

BMI View:

Our long-term outlook for Poland's healthcare system is bright; this will present significant revenue earning opportunities for multinational drugmakers in the years to come. The announced plan to reform the healthcare service will significantly improve access to healthcare, and in particular to highquality treatments such as for cancer, which will boost innovative medicine sales. However, the country's worsening fiscal outlook may require a reduction in the highly ambitious expansion of the healthcare budget, limiting market potential.


Headline Expenditure Projections

- Pharmaceuticals: PLN33.39bn (USD8.86bn) in 2015 to PLN34.93bn (USD8.59bn) in 2016; +4.6% in local currency terms and -3.0% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: PLN114.50bn (USD30.38bn) in 2015 to PLN121.36bn (USD29.85bn) in 2016; +6.0% in local currency terms and -1.7% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Poland Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Poland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Poland 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2014-2020) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q4 2016 31
Poland Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Advertising Regulations 41
Other Regulatory Developments 42
Intellectual Property Regime 43
Pricing And Reimbursement 45
Pricing Regime 46
Reimbursement Regime 48
Market Overview 54
Healthcare Sector 55
Table: Civilian Outpatient Facilities, 2002-2009 57
Table: Healthcare Resources (Poland 2010-2015) 58
Table: Healthcare Personnel (Poland 2010-2015) 59
Poland Pharmaceuticals and Healthcare Report Q4 2016$$
Table: Healthcare Activity (Poland 2010-2015) 59
Research and Development 62
Clinical Trials 63
Epidemiology 64
Competitive Landscape 66
Research-Based Industry 66
Generic Drugmakers 66
Table: Multinational Market Activity 67
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector 69
Table: Number Of Pharmacies In Poland, 2004-2009 70
Company Profile 71
Bioton 71
Polpharma 73
Demographic Forecast 75
Demographic Outlook 75
Table: Population Headline Indicators (Poland 1990-2025) 76
Table: Key Population Ratios (Poland 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Poland 1990-2025) 77
Table: Population By Age Group (Poland 1990-2025) 77
Table: Population By Age Group % (Poland 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.